Hosted on MSN28m
Now Is Not the Time to Undo Adolescent Vaccination Policies
This stands to widen vaccine inequities not only for meningococcal vaccines ... University Law School and served as vice ...
Moderna’s Mixed Performance: Strong Spikevax Sales Drive Q3 Success Amid mRESVIA Uncertainties, Resulting in Hold Rating
Moderna (MRNA – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Tyler Van Buren ...
Mixed Signals from Moderna’s Q3 2024 Performance: Hold Recommendation Issued
Needham analyst Joseph Stringer has maintained their neutral stance on MRNA stock, giving a Hold rating on October 28. Joseph Stringer has ...